Simple jQuery Dropdowns

Browsing by Author Tokyo Metropolitan Komagome Hospital

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
5-Jun-2017Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study<sup>*</sup>Tadeusz Robak; Huiqiang Huang; Jie Jin; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Juliana Pereira; Jiri Mayer; Xiaonan Hong; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Helgi van de Velde; Franco Cavalli; Medical University of Lodz; Sun Yat-Sen University Cancer Center; Zhejiang University School of Medicine; Beijing Cancer Hospital; West China Hospital of Sichuan University; Lobachevsky State University of Nizhni Novgorod; null; KU Leuven– University Hospital Leuven; Mahidol University; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; Universidade de Sao Paulo - USP; Fakultni Nemocnice Brno; Fudan University Shanghai Cancer Center; Tokyo Metropolitan Komagome Hospital; Janssen; Janssen Research and Development; Takeda Oncology; Ospedale San Giovanni
5-Mar-2015Bortezomib-based therapy for newly diagnosed mantle-cell lymphomaTadeusz Robak; Huiqiang Huang; Jie Jin; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Julia Alexeeva; Juliana Pereira; Johannes Drach; Jiri Mayer; Xiaonan Hong; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Helgi Van De Velde; Franco Cavalli; Medical University of Lodz; Sun Yat-Sen University Cancer Center; Zhejiang University School of Medicine; Beijing Cancer Hospital; West China Hospital of Sichuan University; Fudan University Shanghai Cancer Center; Nizhny Novgorod Regional Hospital; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; Federal Center of Heart; Cherkassy Regional Oncology Center; KU Leuven– University Hospital Leuven; Janssen Research and Development; Mahidol University; Universidade de Sao Paulo - USP; Medizinische Universitat Wien; Fakultni Nemocnice Brno; Tokyo Metropolitan Komagome Hospital; Janssen; Janssen Research and Development; Ospedale San Giovanni
1-Jan-2013Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2Shinzaburo Noguchi; Norikazu Masuda; Hiroji Iwata; Hirofumi Mukai; Jun Horiguchi; Puttisak Puttawibul; Vichien Srimuninnimit; Yutaka Tokuda; Katsumasa Kuroi; Hirotaka Iwase; Hideo Inaji; Shozo Ohsumi; Woo Chul Noh; Takahiro Nakayama; Shinji Ohno; Yoshiaki Rai; Byeong Woo Park; Ashok Panneerselvam; Mona El-Hashimy; Tetiana Taran; Tarek Sahmoud; Yoshinori Ito; Osaka University; Osaka National Hospital; Aichi Cancer Center Hospital and Research Institute; National Cancer Center Hospital East; Gunma University Hospital; Prince of Songkla University; Mahidol University; Tokai University; Tokyo Metropolitan Komagome Hospital; Kumamoto University; Osaka Medical Center for Cancer and Cardiovascular Diseases; National Shikoku Cancer Center Hospital; Korea Cancer Center Hospital; National Kyushu Cancer Center; Sagara Hospital; Yonsei University College of Medicine; Novartis Pharmaceuticals Corporation; Cancer Institute Hospital of Japan Foundation for Cancer Research
1-Jan-2000A new polymorphism in the promoter region of the human interleukin-16 (IL-16) geneE. E. Nakayama; C. Wasi; A. Ajisawa; A. Iwamoto; T. Shioda; Institute of Medical Science The University of Tokyo; Mahidol University; Tokyo Metropolitan Komagome Hospital